类他类药物和 Clostridium difficile 引起的肠炎之间的关联:对 MIMIC-IV 数据库的回顾性分析
Renli Wang1, Rongjun Liu2, Hua Wang1
1Department of Intensive Care Unit, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China.
Frontiers in pharmacology
|March 11, 2025
概括
静止剂的使用显著降低了ICU患者中Clostridium difficile诱导肠炎 (CDE) 的发生率. 然而,他类药物似乎没有降低CDE患者的住院死亡率.
科学领域:
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 现有研究表明,他类药物可能会降低 Clostridium difficile 肠炎 (CDE) 的发生率,并改善患者的治疗结果.
- 这项研究调查了在重症监护室 (ICU) 患者中使用他类药物和CDE之间的关系.
研究的目的:
- 为了确定他类药物的使用是否会影响ICU患者中CDE的发病率.
- 评估他类药物使用对患有CDE的ICU患者住院死亡率的影响.
主要方法:
- 利用了来自MIMIC-IV数据库的数据,其中包括51,978名患者.
- 使用多变量逻辑回归,倾向得分匹配 (PSM) 和治疗权重的逆概率 (IPTW) 进行分析.
- 进行了子组分析,以验证不同患者人口统计数据中的发现.
主要成果:
- 类药物与ICU患者中CDE发病率降低有关 (OR:0.758,P<0.05),由PSM和IPTW证实.
- 在使用他类药物 (OR:0.911,P = 0.553) 的CDE的ICU患者中,没有观察到在医院死亡率的显著降低.
- 验证分析 (PSM,IPTW) 和子组分析始终支持这些发现.
结论:
- 静止剂的使用与ICU患者中CDE发病率较低有关.
- 对于被诊断患有CDE的患者来说,使用静止剂并不能显著降低住院死亡率.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
501
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
501
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
433
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
433
Steady State Concentration
4.1K
A steady state refers to the level of a drug in the body once it has reached an equilibrium between administration and elimination. It represents the point at which the drug administration rate equals the drug elimination rate, resulting in a relatively constant concentration in the body over time. The dynamic equilibrium is crucial to ensure the drug's effectiveness with minimal risk of toxicity.
Most drugs are administered in repeated doses at fixed intervals or through continuous...
Most drugs are administered in repeated doses at fixed intervals or through continuous...
4.1K
Dosage Regimen: Fixed Dose
1.8K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.8K
Rational Dosage Regimen: Maintenance Dose and Loading Dose
3.8K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
3.8K
Agonism and Antagonism: Quantification
296
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
296


